Nhóm chiến binh Đảng Công nhân người Kurd giải tán, chấm dứt xung đột với Thổ Nhĩ Kỳ

(Baothanhhoa.vn) - Nhóm chiến binh Đảng Công nhân người Kurd (PKK), vốn đã vướng vào cuộc xung đột đẫm máu với nhà nước Thổ Nhĩ Kỳ trong hơn 4 thập kỷ, đã quyết định giải tán và chấm dứt đấu tranh vũ trang, một hãng thông tấn thân cận với nhóm này đưa tin.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Hy vọng mới trong điều trị ung thư tuyến tụy

Hy vọng mới trong điều trị ung thư tuyến tụy

Thế giới
(Baothanhhoa.vn) - Một loại thuốc thử nghiệm có tên Daraxonrasib đang mở ra hy vọng mới trong điều trị ung thư tuyến tụy, sau khi kết quả nghiên cứu công bố trên tạp chí y khoa New England Journal of Medicine cho thấy thuốc có thể giúp kéo dài gấp đôi thời gian sống...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh